@article{cde8da109b2d442d98ff93995034d8ab,
title = "Corrigendum to {\textquoteleft}A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours{\textquoteright} (European Journal of Cancer (2018) 104 (1–8), (S0959804918309705), (10.1016/j.ejca.2018.07.011))",
abstract = "The authors regret that after publication, the author Emiliano Calvo would like to express the interest of disclosing all his interactions with industry, although not directly relevant to the published work, in the spirit of full transparency. His updated Declaration of Interests disclosure is below. The authors would like to apologize for any inconvenience.",
author = "Anas Gazzah and Valentina Boni and Soria, {Jean Charles} and Antonio Calles and Caroline Even and Bernard Doger and Linda Mahjoubi and Rastislav Bahleda and Mahmoud Ould-Kaci and Anne Esler and Serge Nazabadioko and Emiliano Calvo",
note = "Publisher Copyright: {\textcopyright} 2018",
year = "2019",
month = sep,
day = "1",
doi = "10.1016/j.ejca.2018.12.018",
language = "English",
volume = "119",
pages = "198",
journal = "European Journal of Cancer",
issn = "0959-8049",
}